GL1X · GenesisL1 explorer

Research workbench

Crystal structure of leubat (DELTA13 mutant) in complex with clomipramine

Analyse Crystal structure of leubat (DELTA13 mutant) in complex with clomipramine in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4MMA
Type
protein
Length
504 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transporter
UniProt
O67854
Ligands
CXX, NA
Pockets
5 · best druggability 0.80

Structure

x-ray diffraction · 1 distinct chain · 78% helix, 2% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATransporterprotein50478% helix, 2% strandO67854

Ligands and binding sites

  • CXX · 3-(3-chloro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine · ligand · chains A
  • NA · Sodium ion · metal · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18960.800.8275CXX
2940.530.8417empty
3760.450.8016empty
4700.350.7513empty
5720.340.7514empty

Compared structures

  • 4MMA · Crystal structure of LeuBAT (delta13 mutant) in complex with clomipramine · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.